United States: Blog Series: CMS Proposed Rule On Policy And Technical Changes To The Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid Fee-For-Service, And Medicaid Managed Care Programs For Years 2020 And 2021

On October 26, 2018, the Centers for Medicare and Medicaid Services ("CMS") released for viewing a proposed rule that includes significant changes for Medicare Advantage organizations ("MAOs"), Part D prescription drug plan sponsors ("PDPs"), Medicaid managed care organizations ("MCOs"), and the providers and suppliers that contract with them (the "Proposed Rule"). CMS anticipates that the Proposed Rule will be formally published in the Federal Register on November 1, 2018.

Many of the Proposed Rule's changes would implement provisions of the Bipartisan Budget Act of 2018 (the "BBA"). Another set of proposed changes relate to program integrity initiatives including the preclusion lists that CMS established in the CY2019 MA and PDP final rule, as well as MA risk adjustment data validation ("RADV") audits. Changes to improve program quality and accessibility are also proposed.

This is the first in a series of Sheppard Mullin Healthcare Law Blog posts on the Proposed Rule. The focus of this post is proposed changes relating to RADV audits.

Medicare Advantage Risk Adjustment Data Validation Provisions

RADV is a MAO audit program that is designed by CMS to verify that diagnosis codes submitted for payment by an MAO are supported by medical record documentation for an enrollee. RADV audits for payment year 2007 recouped $13.7 million based on enrollee-level adjustments. No RADV audits were conducted of payment years 2008, 2009 or 2010, as CMS was considering a RADV audit methodology that would provide for contract-level payment error audit findings based on extrapolation.

CMS issued the final RADV audit methodology in February 2012, which provides for sampling techniques and the statistical calculation to be used for extrapolation. The methodology also provides for a fee-for-service adjuster ("FFS Adjuster") as an offset before finalizing any audit recovery. The FFS Adjuster was to account for any effect of erroneous diagnosis codes in the data from Medicare FFS that are used to calibrate the MA risk adjustment model. The FFS Adjuster would be calculated based on a RADV-like audit of Medicare FFS records. CMS has completed that review and, based on its findings, CMS is proposing not to include a FFS Adjuster in any final RADV payment error methodology. See subsection 5 infra. This is an unwelcomed surprise to MAOs, particularly those MAOs that underwent RADV audits for payment years 2011, 2012 and/or 2013 using the final methodology announced in 2012 and have been waiting for CMS' determination of the FFS Adjuster so those audits could be finalized.

CMS proposed the following RADV audit-related changes:

  1. Extrapolation

CMS intends to recover overpayments based on extrapolated audit findings through the use of statistically valid random sampling techniques. CMS uses the Proposed Rule to provide additional notice and seek public input on the agency's methodology for calculating a contract-level payment error in RADV audits, including the sample sizes used in these contract-level audits. CMS notes that it is not required to set forth the methodology for calculating an extrapolated payment error through regulatory provisions, but, in the interest of transparency, is "updating stakeholders on our plans to use various sampling and extrapolation methodologies in RADV audits, as CMS deems appropriate."

CMS is considering other potential methodologies for sampling and extrapolation, which would calculate improper payments made on the audited MA contract for a particular sub-cohort or sub-cohorts. A sub-cohort could be the enrollees for whom a particular hierarchical condition category ("HCC") or one of a related set of HCCs (such as the three diabetes HCCs) was reported. After choosing an MA contract and a sub-cohort or sub-cohorts to audit, CMS would select a statistically significant sample of enrollees for the sub-cohort or sub-cohorts. And, after reviewing the medical records of those enrollees, CMS would use statistical extrapolation to calculate and recoup the improper payments made to the audited MA contract for covering enrollees for the sub-cohort or sub-cohorts in that payment year. CMS believes that the sub-cohort-based audit methodology would allow the agency to focus on cohorts of enrollees that appear to raise programmatic concerns.

In a footnote, CMS indicates that it may begin to conduct RADV audits for payment years 2014 and 2015 before the Proposed Rule is finalized, "pursuant to [CMS'] longstanding authority to review the medical records of any MA enrollee and recoup any improper payments identified." These audits would be designed so that that the individuals selected would form a statistically significant sample that would support an extrapolated recovery, but CMS would not seek to recover on an extrapolated basis until the rule is final. "At the very least, these audits would support enrollee-level recoveries."

  1. Application to Payment Year 2011 and Subsequent Years

The Proposed Rule would apply the finalized RADV payment error methodology or methodologies to payment year 2011 and all subsequent years. CMS does not "expect" to use a sub-cohort based methodology, if finalized, for any payment year before 2014. CMS notes that Section 1871(e)(1)(A) of Social Security Act (42 U.S.C. § 1395hh(e)(1)(A)) authorizes retroactive application of rules where "(i) such retroactive application is necessary to comply with statutory requirements; or (ii) failure to apply the change would be contrary to the public interest." CMS is considering whether application of the finalized methodology or methodologies to payment year 2011 and all subsequent years, would require the exercise of this statutory authority to engage in retroactive rulemaking.

CMS points out that the February 2012 methodology put MAOs on notice that CMS expected to calculate a contract-level payment error for payment year 2011 and beyond by extrapolating from its review of a statistically valid sample of enrollees, and that MAOs have never been entitled to receive or retain payments associated with HCCs that cannot be validated by medical records. "Application of the finalized RADV payment error methodology or methodologies to payment year 2011 and all subsequent years therefore would not upset any settled interest."

  1. Implementation

CMS would recover improper payments based on an extrapolation of the payment error from RADV audit samples to the MAO's specified populations. MAOs would be required to remit extrapolated recovery amounts through CMS' payment system, the Medicare Advantage and Prescription Drug system or "MARx". In the event the recovery amount exceeds an MAO's payment from CMS in one month, the recovery would be spread across multiple months until the full amount is recovered. CMS may likewise require MAOs to remit such recovery amounts based upon audit findings by the Department of Health and Human Services Office of the Inspector General.

  1. Recoupment of Improper Payments in Part C

The Proposed Rule would amend the risk adjustment regulation at 42 C.F.R. § 422.310(e), to require MAOs to remit funds that CMS calculates as improper payments through the extrapolated RADV audit methodology in the manner specified by CMS. RADV audit results can be appealed by MAOs in accordance with § 422.311. CMS is considering changes to the RADV appeal regulations to expand MAOs' appeal rights, including the right to appeal the RADV payment error methodology.

  1. FFS Adjuster

As a follow-up to the February 2012 RADV audit methodology, CMS conducted a study on the presence and impact of diagnosis error in Medicare FFS claims data. According to CMS, the study suggests that errors in FFS claims data do not have any systematic effect on the risk scores calculated by the CMS-HCC risk adjustment model, and therefore do not have any systematic effect on the payments made to MAOs. An executive summary of CMS' study is available on the CMS website.

Interestingly, CMS indicates that, even if it had found that the diagnosis errors in FFS claims data led to systematic payment errors in the MA program, CMS no longer believes that a RADV-specific payment adjustment would be appropriate. CMS notes that RADV audits are used to recover payments based on diagnoses that are not supported by medical record documentation and should not have been reported to CMS. In such cases, the entire payment is in error and should be recovered in full because the payment standard has not been met. Since RADV audits do not address issues with the accuracy of payments based on diagnosis codes that are supported by medical record documentation, CMS believes that an adjustment to RADV recoveries to remedy payment accuracy concerns is inappropriate. CMS believes that it would not be appropriate to correct any systematic payment error in the MA program through a payment adjustment that was only applied to audited contracts. "Doing so would introduce inequities between audited and unaudited plans, by only correcting the payments made to audited plans."

CMS acknowledged the recent district court decision that vacated CMS' Part C and Part D overpayment rule. That decision was the topic of a blog post and webinar by Sheppard Mullin attorneys. CMS is reviewing the decision and "considering its response", but CMS noted that the decision was made on the basis of the administrative record before the court, which did not include the results of CMS' study. This may portend CMS proposing a modified version of the overpayment rule, which continues to define any overpayment as an diagnosis code that is not supported by medical record documentation, but defines when an overpayment has been "identified" consistent with the underlying statute.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
15 Nov 2018, Other, San Diego, United States

The University of San Diego's Center for Cyber Security Engineering and Technology will host this upcoming Symposium in Cyber Law, Risk and Policy to be held on the beautiful USD campus.

15 Nov 2018, Speaking Engagement, San Francisco, United States

EMPOWERED WOMEN MAKING A DIFFERENCE: Give back to your community and change a life with Sheppard Mullin’s Women Lawyers Group

16 Nov 2018, Other, Los Angeles, United States

Sheppard Mullin partner Jonathan Aronie will speak on “Careers in White Collar Practice and Corporate Compliance” panel at Duke Law.

Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions